Environmental Monitoring Performance Qualification

FAQs and practical applications about EMPQ, an important regulatory mandate to safeguard product integrity and patient safety

Understanding Environmental Monitoring Performance Qualification (EMPQ) is essential for maintaining an effective and compliant cleanroom. This article addresses common queries and provides clarity on how newly constructed or significantly renovated facilities can meet the rigorous microbial and particulate standards required for safe products. 

Based on the recently published webinar “CCS Blind Spots: Elevating Cleanroom Validation through Risk-Based EMPQ Strategies”, hosted by Ziva Abraham, President and Founder of Microrite, Inc., and Doug Botkin, Scientific Portfolio Specialist of Charles River, we’ll explore baseline sampling, risk-based monitoring, and the use of consistent microbial identification systems. Learn how to enhance your contamination control strategies and align operations with pharmaceutical regulatory expectations. 

An EMPQ serves as an environmental monitoring validation step, ensuring that cleanrooms and other controlled environments meet the microbial and particulate standards necessary to prevent contamination during production. This process maintains product safety and compliance with regulatory standards.

When should an EMPQ be conducted?

An EMPQ is conducted in newly constructed facilities, or those that have undergone significant renovations or manufacturing shutdowns. The initial EMPQ uses baseline sampling post-construction clean to evaluate the microbiota present before introducing controlled processes and disinfection protocols. This process establishes a baseline understanding of the microbial environment, which varies based on geography, building materials and construction practices. This variability requires a comprehensive and tailored approach to sampling and analysis. High costs associated with manufacturing downtime can increase the pressure from leadership to get the room up and running. This approach aids in the development of routine environmental monitoring (EM) as part of an effective contamination control strategy (CCS) tailored to the specific environmental conditions of each facility.

How does EMPQ help identify root causes of contamination in pharmaceutical manufacturing environments? 

EMPQs help identify root causes for contamination in the manufacturing environment by implementing a risk-based monitoring program. A proper monitoring program detects potentially problematic areas by performing good airflow visualization studies and by understanding personnel flows, material flows, and air flows in the manufacturing environment. This allows for proactive identification of risk sites before they become a problem and allows customers to locate and remove any possible contamination sources.

Are the cleanroom requirements for production also applicable to cleanrooms used in quality control, such as sterility testing?

Yes, the cleanroom requirements for production are also applicable to cleanrooms used in quality control, like those used for sterility testing. The sterility testing suite usually operates within a cleanroom environment, even though it may be in your quality control lab and still has similar requirements. Maintaining the same level of cleanliness throughout a manufacturing environment and following standards is important, as sterility testing is as critical as production processes.

EMPQ Essentials for Successful Cleanroom Qualifications 
Whether you are setting up a new EMPQ program or enhancing an existing one, equip yourself with actionable, data-driven, insights to enhance your microbial identification processes and reinforce your facility’s quality control.
Watch On Demand

What factors form a reliable risk assessment strategy?

A reliable risk assessment strategy is built on several factors. Thorough pre-EMPQ activities, like Computational Fluid Dynamics (CFD) analysis and airflow visualization, should be first used to identify any potential risk areas. Then, it is important to determine whether pre-PQ activities have been performed and executed correctly and if potential risks have been properly identified before developing the full protocol. Understanding the environment, processes, personnel and material flow within the areas being assessed is also essential for a comprehensive risk assessment. A comprehensive understanding of your environment, as well as your processes and personnel material flow is necessary to understand what’s going on and to properly assess and mitigate risks.

Is there a different approach to using the risk assessment for EU guidelines versus ISO guidelines?

ISO standards do not directly cover risk assessments, but we use them as guidance for cleanroom validations, specifically ISO 14644-1. They are revised periodically, and new standards are continually being built. EU regulations, like the ones outlined in Annex 1, discuss risk assessments more directly. It is important to understand the hierarchy of regulations, standards, and guidelines, with regulations taking priority. Regulations are your requirements and standards are what guide you to meet the requirements.

Is there a way to conduct EM sampling for anaerobic microbes in a fully aerobic environment?

It is difficult to sample for an anaerobic organism in a fully aerobic environment because they are unable to grow in oxygen-rich areas. During the EMPQ process, it is important to understand the environmental factors that allow anaerobic growth to thrive or be inhibited. Anaerobes do not normally thrive in oxygen-rich environments, but there are exceptions with facultative anaerobes, like Propionibacterium species, which can tolerate some levels of oxygen. 

These are normally very rare and sometimes go undetected during routine environmental monitoring. It’s important to understand your manufacturing process and use a risk-based approach for sampling. For example, anaerobic contamination can occur when gases like nitrogen are used, and this can help provide a strong scientific justification for implementing a rigorous sampling protocol to test for anaerobes.

How does EMPQ facilitate regulatory compliance and audit readiness for pharmaceutical companies? 

An EMPQ is a regulatory requirement and is the justification for routine EM sampling and frequency. If a risk is not properly addressed during the EMPQ process, it can pose contamination risks for your manufacturing processes down the road.  A properly executed EMPQ ensures risks are identified and mitigated to avoid inadequate root cause analyses or ineffective CAPAs. An EMPQ demonstrates a proactive stance and facilitates regulatory compliance because it provides valuable insight for cleanroom behaviors under operational and static conditions, allowing for a comprehensive risk management program.

If DNA is the gold standard for IDs, what is the advantage of using MALDI-TOF technology?

DNA sequencing is the gold standard for identification as it is the most accurate and robust methodology available, especially when combined with the comprehensive phylogenetic analysis that our AccuGENX-ID^® services provide. For routine EM work, MALDI-TOF technology (either with our Axcess^® system or our AccuPRO-ID^® services) can provide some advantages over DNA sequencing when used with Charles River’s expansive database. MALDI-TOF can reduce time-to-result, provide a cost-effective ID solution, and significantly improve microbial ID quality when compared to phenotypic methods.

DNA sequencing, however, is the method of choice for critical samples (sterility or media fill failures, OOS, and other investigative samples) and cleanroom qualification baseline and EMPQ sampling since it provides the overall fastest time to result and highest accuracy. If MALDI-TOF methods are used for critical samples and cleanroom qualification work, time-to-result can be impacted due to the requirement for fresh cultures and the potential for added time due to the sequencing backup service we provide with MALDI-TOF samples.

Can I use my in-house system to ID my EMPQ samples and use Accugenix^® for routine Environmental Monitoring samples? 

The EMPQ is especially crucial for a company’s contamination control strategy. Many manufacturing environments prefer to use their in-house systems, but it’s important to consider what library is being used and if they are being consistent. Using a different library for your EMPQ than for routine environmental sampling could lead to data comparability gaps because there might be variations in how different libraries identify organisms. It is best to use the same microbial library throughout a microbial identification program for consistent and reliable data analysis. Additionally, many in-house systems have a clinical bias to their library entries and/or have relatively small libraries, limiting the utility of these systems for use in pharmaceutical facilities. The result of using libraries limited by breadth or size is an increase in the number of ‘No ID’ results and misidentifications, both of which can significantly increase the overall cost and quality impact of a microbial identification program. Given the resource limitations and pressure during an EMPQ, manufacturers may find it easier and faster to outsource IDs.

For more details on these radio- and disinfectant- resistant microorganisms, watch our exclusive on-demand video series (only available for a limited time) presented by Ziva Abraham, President and Founder of Microrite, Inc. and Duncan Barlow, Scientific Portfolio Specialist, for Charles River Laboratories’ Microbial Solutions division.

Micayla Crozier is a Commercial Training Specialist with the Manufacturing Team at Charles River.